产品中心
当前位置：首页>产品中心Anti-MIPEP/Cy5.5
货号： bs-18945R-Cy5.5 基本售价： 2980.0 元 规格： 100ul
产品信息
- 产品编号
- bs-18945R-Cy5.5
- 英文名称
- Anti-MIPEP/Cy5.5
- 中文名称
- Cy5.5标记的线粒体中间肽酶抗体
- 别 名
- EC 3.4.24.59; HMIP; MIP; Mipep; MIPEP_HUMAN; Mitochondrial intermediate peptidase; Mitochondrial intermedieate peptide; OTTHUMP00000018121; OTTHUMP00000042292.
- 规格价格
- 100ul/2980元购买 大包装/询价
- 说 明 书
- 100ul
- 研究领域
- 细胞生物 新陈代谢
- 抗体来源
- Rabbit
- 克隆类型
- Polyclonal
- 交叉反应
- Human, Mouse, Rat, Pig, Horse, Rabbit,
- 产品应用
- ICC=1:50-200 IF=1:50-200
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
- 分 子 量
- 77kDa
- 性 状
- Lyophilized or Liquid
- 浓 度
- 1mg/ml
- 免 疫 原
- KLH conjugated synthetic peptide derived from human MIPEP
- 亚 型
- IgG
- 纯化方法
- affinity purified by Protein A
- 储 存 液
- 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
- 保存条件
- Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
- 产品介绍
- background:
The product of this gene performs the final step in processing a specific class of nuclear-encoded proteins targeted to the mitochondrial matrix or inner membrane. This protein is primarily involved in the maturation of oxidative phosphorylation (OXPHOS)-related proteins. This gene may contribute to the functional effects of frataxin deficiency and the clinical manifestations of Friedreich ataxia. [provided by RefSeq, Jul 2008]
Function:
Cleaves proteins, imported into the mitochondrion, to their mature size.
Subcellular Location:
Mitochondrion matrix.
Similarity:
Belongs to the peptidase M3 family.
Database links:Entrez Gene: 4285Human
Omim: 602241Human
SwissProt: Q99797Human
Unigene: 507498Human
Important Note:
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.